Skip to main content

CSL CEO Paul Perreault on Getting Back to Australia

“It is personal. My headquarters are in Melbourne, I want to get back,” Perreault tells the Australian Financial Review’s BOSS magazine.

CSL CEO Paul Perreault in the outdoors

CSL Limited CEO Paul Perreault recently visited CSL Behring offices in King of Prussia, Pennsylvania. In May, he dropped in on the Seqirus flu vaccine manufacturing site in Holly Springs, North Carolina. But he’d really like to hop one of those long, long flights to Australia, Perreault, who lives in Utah, recently told the Australian Financial Review’s BOSS magazine.

He said he hoped Australia, with increased vaccinations, would loosen restrictions that still require even vaccinated travelers to quarantine for two weeks. In the extended interview, Perreault covered a range of topics, including CSL’s massive effort to produce millions of doses of the AstraZeneca COVID-19 vaccine and the prospect of an mRNA vaccine manufacturing site in Australia.

See the full story: CSL chief’s personal mission to get Australia vaccinated